Free Trial

Avadel Pharmaceuticals (AVDL) Competitors

Avadel Pharmaceuticals logo
$10.65 +0.27 (+2.60%)
Closing price 04:00 PM Eastern
Extended Trading
$10.64 -0.01 (-0.05%)
As of 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVDL vs. ACLX, MRUS, ZLAB, SRRK, ACAD, VKTX, SWTX, PTGX, MLTX, and IMVT

Should you be buying Avadel Pharmaceuticals stock or one of its competitors? The main competitors of Avadel Pharmaceuticals include Arcellx (ACLX), Merus (MRUS), Zai Lab (ZLAB), Scholar Rock (SRRK), ACADIA Pharmaceuticals (ACAD), Viking Therapeutics (VKTX), SpringWorks Therapeutics (SWTX), Protagonist Therapeutics (PTGX), MoonLake Immunotherapeutics (MLTX), and Immunovant (IMVT). These companies are all part of the "pharmaceutical products" industry.

Avadel Pharmaceuticals vs. Its Competitors

Arcellx (NASDAQ:ACLX) and Avadel Pharmaceuticals (NASDAQ:AVDL) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Avadel Pharmaceuticals has higher revenue and earnings than Arcellx. Avadel Pharmaceuticals is trading at a lower price-to-earnings ratio than Arcellx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arcellx$107.94M36.10-$107.35M-$2.99-23.65
Avadel Pharmaceuticals$169.12M6.09-$48.83M-$0.27-39.44

Avadel Pharmaceuticals has a net margin of -13.58% compared to Arcellx's net margin of -211.46%. Arcellx's return on equity of -35.27% beat Avadel Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Arcellx-211.46% -35.27% -22.73%
Avadel Pharmaceuticals -13.58%-36.07%-16.30%

96.0% of Arcellx shares are held by institutional investors. Comparatively, 69.2% of Avadel Pharmaceuticals shares are held by institutional investors. 8.4% of Arcellx shares are held by company insiders. Comparatively, 5.2% of Avadel Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Arcellx has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, Avadel Pharmaceuticals has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500.

In the previous week, Avadel Pharmaceuticals had 2 more articles in the media than Arcellx. MarketBeat recorded 4 mentions for Avadel Pharmaceuticals and 2 mentions for Arcellx. Arcellx's average media sentiment score of 1.58 beat Avadel Pharmaceuticals' score of 0.79 indicating that Arcellx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Arcellx
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Avadel Pharmaceuticals
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Arcellx currently has a consensus target price of $111.23, indicating a potential upside of 57.33%. Avadel Pharmaceuticals has a consensus target price of $18.17, indicating a potential upside of 70.58%. Given Avadel Pharmaceuticals' higher probable upside, analysts clearly believe Avadel Pharmaceuticals is more favorable than Arcellx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arcellx
0 Sell rating(s)
0 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
3.07
Avadel Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Arcellx beats Avadel Pharmaceuticals on 9 of the 17 factors compared between the two stocks.

Get Avadel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVDL vs. The Competition

MetricAvadel PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.00B$2.42B$5.52B$9.32B
Dividend YieldN/A1.79%4.25%4.05%
P/E Ratio-39.449.1828.1519.68
Price / Sales6.09736.93437.63100.28
Price / CashN/A160.6835.5357.53
Price / Book13.834.698.235.67
Net Income-$48.83M$30.99M$3.23B$257.51M
7 Day Performance11.52%0.60%-0.01%0.52%
1 Month Performance12.11%7.93%5.61%8.84%
1 Year Performance-37.02%-5.48%26.52%14.18%

Avadel Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVDL
Avadel Pharmaceuticals
1.8485 of 5 stars
$10.65
+2.6%
$18.17
+70.6%
-37.3%$1.00B$169.12M-39.4470
ACLX
Arcellx
2.4906 of 5 stars
$69.92
+1.4%
$111.23
+59.1%
+7.6%$3.85B$76.81M-23.3880News Coverage
Positive News
MRUS
Merus
1.9238 of 5 stars
$55.62
+2.1%
$84.64
+52.2%
-5.4%$3.85B$36.13M-13.6337News Coverage
ZLAB
Zai Lab
3.2894 of 5 stars
$34.28
+4.7%
$54.28
+58.3%
+95.5%$3.81B$398.99M-13.771,869
SRRK
Scholar Rock
3.0717 of 5 stars
$38.59
+3.1%
$42.67
+10.6%
+320.8%$3.66B$33.19M-15.25140
ACAD
ACADIA Pharmaceuticals
4.0819 of 5 stars
$21.89
+4.3%
$27.88
+27.3%
+22.1%$3.66B$957.80M15.98510Analyst Revision
VKTX
Viking Therapeutics
4.6176 of 5 stars
$31.63
+1.7%
$87.15
+175.5%
-48.3%$3.55BN/A-27.5020Positive News
Upcoming Earnings
Gap Up
SWTX
SpringWorks Therapeutics
1.5998 of 5 stars
$46.99
flat
$52.57
+11.9%
N/A$3.54B$191.59M-13.78230Positive News
PTGX
Protagonist Therapeutics
1.448 of 5 stars
$55.23
+4.2%
$66.10
+19.7%
+50.5%$3.42B$434.43M73.64120Positive News
MLTX
MoonLake Immunotherapeutics
1.7293 of 5 stars
$50.86
+3.8%
$74.50
+46.5%
+1.6%$3.26BN/A-22.112
IMVT
Immunovant
1.3583 of 5 stars
$18.59
+2.5%
$36.30
+95.3%
-42.7%$3.18BN/A-6.78120Positive News

Related Companies and Tools


This page (NASDAQ:AVDL) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners